LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Françoise Railhet <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Sat, 10 Apr 1999 22:34:07 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (25 lines)
What is the reason and the dose for the treatment with methotrexate ?
One study about it, about a mother who received  22,5 mg/day for a
choriocarcinome. Ratio moil/plasma was 0,08, and the cumulative excretion in
breast milk in the first 12 hours was only 0,32 µg. The passage is very low,
but the methotrexate is very toxic, and breastfeeding is contrindicated when
the mother is treated for a cancer.

Methotrexate is used too at low doses for arthritis or autoimmunologic
disorders. In this case, beastfeeding is possible as the level in breast
milk is insignificant. Infant has to be monitored (anemia), and folic acid
can be given to him.

It has half live is 2 to 8 hours.

Kindly
Francoise Railhet
LLL France Medical Associates program
[log in to unmask]

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2